journal article·2026-01-30Open access

Preparation of Uniform PEG-PLLA Microspheres via Membrane Emulsification for Soft Tissue Filling Applications

Siqi Zhang, Yuan Gao, Danyang Wang, Yongjie Chi, Fang Wu, Lianyan Wang, Hailan Jin

Abstract

Skin aging could lead to dermal collagen loss and elastic fiber degradation, ultimately manifesting as skin laxity. We aimed to counteract this by using poly-L-lactic acid (PLLA) microsphere (MS)-based fillers to facilitate long-term volume restoration through collagen regeneration. However, conventional MSs exhibit limitations such as broad size distribution and surface irregularities, which are frequently associated with significant adverse reactions. This study employed shirasu porous glass (SPG) membrane emulsification to fabricate uniform and well-shaped polyethylene glycol-block-poly (L-lactic acid) (PEG-PLLA) MSs. A single-factor experiment was employed to optimize the parameters. The optimal preparation conditions for PEG-PLLA MSs were as follows: PEG-PLLA concentration of 40 mg/mL, polyvinyl alcohol (PVA) concentration of 0.5%, and magnetic stirring speed of 200 rpm. Under the optimal conditions, the average particle size of PEG-PLLA MSs was 58.982 μm, and the span value (SPAN) was 1.367. In addition, a cytotoxicity assay was performed, and the results revealed no significant toxicity of the MSs toward L929 mouse fibroblasts at concentrations below 500 μg/mL. Furthermore, PEG-PLLA MSs significantly enhanced the production of key extracellular matrix (ECM) components—type I collagen (Col-I), type III collagen (Col-III), and hyaluronic acid (HA)—while simultaneously alleviating cellular oxidative stress responses. This work offers a reliable and reproducible fabrication strategy for developing biocompatible MS fillers with controllable particle sizes.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Facial Rejuvenation and Surgery Techniques · Skin Protection and Aging · Collagen: Extraction and Characterization

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Key Laboratory of Bio-Based Material Science & Technology, Ministry of Education, Northeast Forestry University, Harbin 150040, China

Institute of Process Engineering, Chinese Academy of Sciences, Beijing 100190, China

School of Chemical Engineering, University of Chinese Academy of Sciences, Beijing 100190, China

College of Pharmacy, Heilongjiang University of Chinese Medicine, Harbin 150040, China

Funding

Beijing Natural Science Foundation · GuoTai (Taizhou) Center of Technology Innovation for Veterinary Biologicals Program · Industrial Key Science and Technology Program in Taizhou

References (70)

Show source-provided references
1. Five-factor theory of aging and death due to aging10.1016/j.archger.2024.105665 ↗
2. Mechanisms and treatments of photoaging10.1111/phpp.12145 ↗
3. The dynamic anatomy and patterning of skin10.1111/exd.12832 ↗
4. Evaluation of Paste-Type Micronized Acellular Dermal Matrix for Soft Tissue Augmentation: Volumetric and Histological Assessment in a Mouse Model10.1007/s00266-022-03051-x ↗
5. Perforator-based local flaps for cutaneous facial reconstruction10.1186/s40902-024-00435-8 ↗
6. Ansari Lari, S., Zumot, M.S., Nemrish, S., and Fredericks, S. (2024). Role of mesenchymal cells in enhancing cosmetic outcomes for autologous augmented fat transfers for facial rejuvenation and reconstructive surgery. Front. Med., 11.10.3389/fmed.2024.1466939 ↗
7. Collagen Stimulators in Body Applications: A Review Focused on Poly-L-Lactic Acid (PLLA)10.2147/CCID.S359813 ↗
8. Comprehensive Systematic Review of Poly-L-lactic Acid in Facial Clinical Application10.1007/s00266-024-04098-8 ↗
9. Optimizing injectable poly-L-lactic acid administration for soft tissue augmentation: The rationale for three treatment sessions10.1177/229255031101900311 ↗
10. Late-onset granuloma formation after poly-L-lactic acid injection10.1016/j.jdcr.2015.11.017 ↗
11. Effect of Synthesis Parameters on Size of the Biodegradable Poly (L-Lactide) (PLLA) Microspheres
12. Biodegradable Magnesium-Incorporated Poly(L-lactic acid) Microspheres for Manipulation of Drug Release and Alleviation of Inflammatory Response10.1021/acsami.9b03766 ↗
13. Phagocytosis of different particulate dermal filler substances by human macrophages and skin cells
14. Investigating the Effect of Biomaterials Such as Poly-(L-Lactic Acid) Particles on Collagen Synthesis In Vitro: Method Is Matter10.3390/jfb11030051 ↗
15. PLLA-PEG/mPEG Copolymer with Improved Hydrophilicity, Crystallinity, and Biocompatibility: An In-Depth Study on the Crystallization Kinetics10.1021/acsami.5c02818 ↗
16. miRNA-142-3p aggravates hydrogen peroxide-induced human umbilical vein endothelial cell premature senescence by targeting SIRT110.1042/BSR20231511 ↗
17. A Feedback Loop Driven by H4K12 Lactylation and HDAC3 in Macrophages Regulates Lactate-Induced Collagen Synthesis in Fibroblasts Via the TGF-β Signaling10.1002/advs.202411408 ↗
18. Mossy-textured hydroxyapatite-modified poly (lactic-co-glycolic acid) microspheres promote collagen regeneration via calcium/TGF-β and chemokine signaling pathways in soft tissue augmentation
19. Evrard, C., Lambert de Rouvroit, C., and Poumay, Y. (2021). Epidermal Hyaluronan in Barrier Alteration-Related Disease. Cells, 10.10.3390/cells10113096 ↗
20. Recent advances in exploring the properties and applications of hyaluronan10.1016/j.jdsct.2024.100039 ↗
21. Depolymerization and Re/Upcycling of Biodegradable PLA Plastics10.1021/acsomega.3c08674 ↗
22. Observation of Ferroelectric Lithography on Biodegradable PLA Films10.1002/adma.202307936 ↗
23. Evaluation of unidirectional BGF/PLA and Mg/PLA biodegradable composites bone plates-scaffolds assembly for critical segmental fractures healing10.1016/j.compositesa.2020.105929 ↗
24. Antibacterial PLA/Mg composite with enhanced mechanical and biological performance for biodegradable orthopedic implants10.1016/j.bioadv.2023.213523 ↗
25. Mechanical, crystallisation and moisture absorption properties of melt drawn polylactic acid fibres10.1016/j.eurpolymj.2014.02.001 ↗
26. Acceleration of crystallisation rate in injection moulded PLLA by stereocomplex formation10.1088/2053-1591/abbeba ↗
27. Effect of the simultaneous biaxial stretching on the structural and mechanical properties of PLA, PBAT and their blends at rubbery state10.1016/j.eurpolymj.2015.05.001 ↗
28. Phase-selective conductivity enhancement and cooperativity length in PLLA/TPU nanocomposite blends with carboxylated carbon nanotubes10.1016/j.polymer.2020.122279 ↗
29. Influence of Chain Architectures on Crystallization Behaviors of PLLA Block in PEG/PLLA Block Copolymers10.1007/s10118-019-2202-7 ↗
30. Confined PEO crystallisation in immiscible PEO/PLLA blends10.1039/C6RA02406H ↗
31. Compositions of injectable poly-D,L-lactic acid and injectable poly-L-lactic acid10.1111/ced.14085 ↗
32. Practices in the Usage and Reconstitution of Poly-L-Lactic Acid
33. Safety and Efficacy of Poly-L-Lactic Acid Filler (Gana V vs. Sculptra) Injection for Correction of the Nasolabial Fold: A Double-Blind, Non-Inferiority, Randomized, Split-Face Controlled Trial10.1007/s00266-023-03600-y ↗
34. Nodules on the Anterior Neck Following Poly-L-lactic Acid Injection10.12788/cutis.0555 ↗
35. Late Onset Foreign Body Reaction due to Poly-L-Lactic Acid Facial Injections for Cosmetic Purpose10.5021/ad.2020.32.6.519 ↗
36. Effect of PEG addition on pore morphology and biocompatibility of PLLA scaffolds prepared by freeze drying10.1007/s13534-016-0241-3 ↗
37. Clinical applications of a novel poly-L-lactic acid microsphere and hyaluronic acid suspension for facial depression filling and rejuvenation10.1111/jocd.16446 ↗
38. Lorenc, Composition and mechanism of action of poly-L-lactic acid in soft tissue augmentation
39. Biodegradable PLLA/PLGA microspheres/collagen composites for continuous soft tissue augmentation10.1016/j.compositesb.2024.111603 ↗
40. The membrane emulsification process—A review10.1002/jctb.969 ↗
41. Preparation of uniform-sized hemoglobin-albumin microspheres as oxygen carriers by Shirasu porous glass membrane emulsification technique10.1016/j.colsurfb.2015.01.018 ↗
42. Preparation of Uniform-Sized Poly[methacryloxypropyl Tris(trimethylsiloxy)silane] Microspheres via Shirasu Porous Glass Membrane Emulsification Technique10.1252/jcej.13we100 ↗
43. Size-controlled and monodisperse enzyme-encapsulated chitosan microspheres developed by the SPG membrane emulsification technique10.1016/j.jcis.2011.12.078 ↗
44. Uniform-sized PLA nanoparticles: Preparation by premix membrane emulsification10.1016/j.ijpharm.2008.03.027 ↗
45. Continuous in-line homogenization process for scale-up production of naltrexone-loaded PLGA microparticles10.1016/j.jconrel.2020.06.023 ↗
46. Particle control of emulsion by membrane emulsification and its applications10.1016/S0169-409X(00)00099-5 ↗
47. Membrane emulsification: Droplet size and uniformity in the absence of surface shear10.1016/j.memsci.2008.01.009 ↗
48. Liquid−Liquid Membrane Dispersion in a Stirred Cell with and without Controlled Shear10.1021/ie0504699 ↗
49. Facile preparation of multifunctional superparamagnetic PHBV microspheres containing SPIONs for biomedical applications10.1038/srep23140 ↗
50. Time-dependent specific molecular signatures of inflammation and remodelling are associated with trimethylamine-N-oxide (TMAO)-induced endothelial cell dysfunction10.1038/s41598-023-46820-7 ↗
51. Lactate triggers KAT8-mediated LTBP1 lactylation at lysine 752 to promote skin rejuvenation by inducing collagen synthesis in fibroblasts10.1016/j.ijbiomac.2024.134482 ↗
52. Recent progress in preventive effect of collagen peptides on photoaging skin and action mechanism10.1016/j.fshw.2021.11.003 ↗
53. Pittayapruek, P., Meephansan, J., Prapapan, O., Komine, M., and Ohtsuki, M. (2016). Role of Matrix Metalloproteinases in Photoaging and Photocarcinogenesis. Int. J. Mol. Sci., 17.10.3390/ijms17060868 ↗
54. Coexpression of the superoxide dismutase and the catalase provides remarkable oxidative stress resistance in Lactobacillus rhamnosus10.1021/jf200251k ↗
55. Several lines of antioxidant defense against oxidative stress: Antioxidant enzymes, nanomaterials with multiple enzyme-mimicking activities, and low-molecular-weight antioxidants10.1007/s00204-024-03696-4 ↗
56. Lipid peroxidation: Production, metabolism, and signaling mechanisms of malondialdehyde and 4-hydroxy-2-nonenal10.1155/2014/360438 ↗
57. Collagens at a glance10.1242/jcs.03453 ↗
58. The collagen family
59. Collagen Fibril Assembly and Function10.1016/bs.ctdb.2018.02.004 ↗
60. Davison-Kotler, E., Marshall, W.S., and García-Gareta, E. (2019). Sources of Collagen for Biomaterials in Skin Wound Healing. Bioengineering, 6.10.3390/bioengineering6030056 ↗
61. Amirrah, I.N., Lokanathan, Y., Zulkiflee, I., Wee, M., Motta, A., and Fauzi, M.B. (2022). A Comprehensive Review on Collagen Type I Development of Biomaterials for Tissue Engineering: From Biosynthesis to Bioscaffold. Biomedicines, 10.10.3390/biomedicines10092307 ↗
62. Aminoterminal propeptide of type III procollagen in healing wound in humans10.1097/00000658-198712000-00011 ↗
63. Type III collagen is crucial for collagen I fibrillogenesis and for normal cardiovascular development10.1073/pnas.94.5.1852 ↗
64. Supramolecular hydrogel networks formed by molecular recognition of collagen and a peptide grafted to hyaluronic acid10.1016/j.actbio.2016.04.018 ↗
65. A high clinically translatable strategy to anti-aging using hyaluronic acid and silk fibroin co-crosslinked hydrogels as dermal regenerative fillers10.1016/j.apsb.2025.04.020 ↗
66. Skin ageing and its treatment10.1002/path.2098 ↗
67. Laronha, H., and Caldeira, J. (2020). Structure and Function of Human Matrix Metalloproteinases. Cells, 9.10.3390/cells9051076 ↗
68. Activity of matrix metalloproteinase-9 against native collagen types I and III10.1111/j.1742-4658.2007.05669.x ↗
69. The type of variants at the COL3A1 gene associates with the phenotype and severity of vascular Ehlers-Danlos syndrome10.1038/ejhg.2015.32 ↗
70. Żynda, W., Ruczaj, A., and Galicka, A. (2025). Natural Compounds with Beneficial Effects on Skin Collagen Type I and Mechanisms of Their Action. Antioxidants, 14.10.3390/antiox14040389 ↗